Large-scale testing (Phase 3)Study completedNCT00549562What this trial is testingStudy of Paliperidone ER in Adolescents and Young Adults With AutismWho this might be right forAutism Indiana University 25
Large-scale testing (Phase 3)WithdrawnNCT06585969What this trial is testingA Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast CancerWho this might be right forMetastatic Breast CancerER-positive Breast CancerLuminal B+2 more Danish Breast Cancer Cooperative Group
Early research (Phase 1)Ended earlyNCT00972023What this trial is testingDHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast CancerWho this might be right forBreast Cancer Barbara Ann Karmanos Cancer Institute 1
Not applicableStudy completedNCT00750958What this trial is testingPREVENT - Prospective Rhythm Event Surveillance in the ER With NetGuardWho this might be right forCardiac Event Datascope Patient Monitoring 287
Post-approval studies (Phase 4)Study completedNCT00524043What this trial is testingAn Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With SchizophreniaWho this might be right forSchizophrenia Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201
Large-scale testing (Phase 3)Study completedNCT00390455What this trial is testingFulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-PositiveWho this might be right forEstrogen Receptor PositiveHER2 Positive Breast CarcinomaHER2/Neu Negative+5 more National Cancer Institute (NCI) 295
Early research (Phase 1)Active Not RecruitingNCT04188548What this trial is testingLY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial CancerWho this might be right forBreast CancerAdvanced Breast CancerMetastatic Breast Cancer+1 more Eli Lilly and Company 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07410559What this trial is testingNeoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast CancerWho this might be right forBreast Cancer Fudan University 189
Testing effectiveness (Phase 2)Study completedNCT00755885What this trial is testingAbiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Cancer Research UK 77
Early research (Phase 1)Study completedNCT05452785What this trial is testingA Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human SubjectsWho this might be right forPharmacokinetics Journey Medical Corporation 24
Not applicableStudy completedNCT00696813What this trial is testingObservational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral AntipsychoticsWho this might be right forSchizophrenia Janssen-Cilag International NV 3,064
Testing effectiveness (Phase 2)Looking for participantsNCT06000917What this trial is testingNeoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast CancerWho this might be right forBreast CancerNeoadjuvant Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 62
Early research (Phase 1)Active Not RecruitingNCT05509790What this trial is testingLY3484356 in Chinese Participants With Advanced Breast CancerWho this might be right forBreast Neoplasms Eli Lilly and Company 17
Testing effectiveness (Phase 2)UnknownNCT02681562What this trial is testingOlaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer PatientsWho this might be right forBreast CancerTriple Negative Breast Cancer Istituti Ospitalieri di Cremona 45
Testing effectiveness (Phase 2)Looking for participantsNCT07159451What this trial is testingA Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast CancerWho this might be right forBreast Cancer Gustave Roussy, Cancer Campus, Grand Paris 140
Testing effectiveness (Phase 2)Ended earlyNCT00517361What this trial is testingPhase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer University of Chicago 11
Large-scale testing (Phase 3)Study completedNCT00348010What this trial is testingA Study Comparing the Effectiveness and Safety of Extended Release Tramadol Versus Placebo for the Treatment of Osteoarthritis (OA) of the KneeWho this might be right forChronic Pain Bausch Health Americas, Inc. 245
Early research (Phase 1)Looking for participantsNCT07525141What this trial is testingJNJ-1761981 in Participants With Solid TumorsWho this might be right forNeoplasms Johnson & Johnson Enterprise Innovation Inc. 66
Not applicableStudy completedNCT04010929What this trial is testingEfficacy of Er,Cr:YSGG Laser in Partial PupotomyWho this might be right forLaserToothPulpotomy Merve Erkmen Almaz 64
Testing effectiveness (Phase 2)Study completedNCT01421472What this trial is testingA Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast CancerWho this might be right forER Positive, Her2 Negative Breast Cancer PatientsTriple Negative Breast Cancer Patients Merrimack Pharmaceuticals 196